| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | ANKUB1 NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 6.69e-06 | 248 | 184 | 12 | 1.25.40.20 |
| Domain | ANK | ANKUB1 NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 7.56e-06 | 251 | 184 | 12 | SM00248 |
| Domain | Ankyrin_rpt-contain_dom | ANKUB1 NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 8.52e-06 | 254 | 184 | 12 | IPR020683 |
| Domain | Ankyrin_rpt | ANKUB1 NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 1.16e-05 | 262 | 184 | 12 | IPR002110 |
| Domain | Ank | NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 1.68e-05 | 228 | 184 | 11 | PF00023 |
| Domain | ANK_REPEAT | NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 4.37e-05 | 253 | 184 | 11 | PS50088 |
| Domain | ANK_REP_REGION | NFKBID ANKRD50 ANKS4B NFKB2 NFKBIL1 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 4.53e-05 | 254 | 184 | 11 | PS50297 |
| Domain | Ank_2 | NFKBID ANKRD50 ANKS4B NFKB2 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 5.56e-05 | 215 | 184 | 10 | PF12796 |
| Domain | Filaggrin | 9.65e-05 | 2 | 184 | 2 | IPR003303 | |
| Domain | SAM | 2.34e-04 | 88 | 184 | 6 | SM00454 | |
| Domain | SAM_DOMAIN | 3.54e-04 | 95 | 184 | 6 | PS50105 | |
| Domain | SAM | 3.96e-04 | 97 | 184 | 6 | IPR001660 | |
| Domain | G2F | 5.72e-04 | 4 | 184 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 5.72e-04 | 4 | 184 | 2 | PS50993 | |
| Domain | GFP | 5.72e-04 | 4 | 184 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 5.72e-04 | 4 | 184 | 2 | IPR006605 | |
| Domain | - | 6.36e-04 | 106 | 184 | 6 | 1.10.150.50 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 MAN2A2 SEMA7A MYO9B PPRC1 PAPLN KLF4 HDAC7 JAG2 NHSL1 BMP8B RADIL INTS5 KANSL1 NAPRT NFKB2 ZNF516 BANP EHMT1 COBL PLA2G6 PLEC HERC2 IL17RD FEM1A MYRF ADAT1 NOTCH2 AHNAK2 | 3.15e-12 | 1105 | 191 | 29 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SLC4A7 UBAP2 SASH1 TRIP6 PATZ1 WWTR1 MCCC1 HDAC7 STIM1 NHSL1 STOX2 RADIL DCP1B DOCK7 COBL BOD1L1 PLEC FGD6 NOTCH2 AHNAK2 | 6.92e-08 | 861 | 191 | 20 | 36931259 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | EPHB4 SMG1 MARCHF6 URB2 SDR39U1 GDE1 TRMT6 MOGS MICB NFKB2 COBL ASB1 HERC2 FGD6 MYRF TMUB2 NOTCH2 | 5.48e-07 | 719 | 191 | 17 | 35337019 |
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 32209652 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ELOA ZNF142 SLC4A7 UBAP2 ZNF275 URB2 GDE1 STIM1 EEF2 INTS5 LMF2 MOGS DOCK7 GOLIM4 LSS TNKS PLEC TMUB2 SLX4 NOTCH2 | 1.16e-05 | 1203 | 191 | 20 | 29180619 |
| Pubmed | FLG SMG1 NOL4 ZNF536 UBAP2 TRIP6 ZNF318 MCCC1 FLG2 KLF4 DDB1 KANSL1 DCP1B PDCD5 NFKB2 ZNF516 BANP EHMT1 HERC2 PSMD14 SLX4 FILIP1L | 1.37e-05 | 1429 | 191 | 22 | 35140242 | |
| Pubmed | NOL4 SAMD1 SCO2 ZNF536 HDAC6 TRIP6 PATZ1 ZNF212 BUD13 ZKSCAN2 ZNF318 DDB1 HMCN2 EML5 KMT5B NFKBIL1 EHMT1 XYLB NOTCH2 | 1.40e-05 | 1116 | 191 | 19 | 31753913 | |
| Pubmed | 2.33e-05 | 153 | 191 | 7 | 10718198 | ||
| Pubmed | UBAP2 PATZ1 ZNFX1 ZNF318 DDB1 SPTBN4 LRIG2 STOX2 EEF2 ZNF516 DOCK7 DCHS1 EHMT1 ADGRA1 TNKS HERC2 NOS1 | 2.58e-05 | 963 | 191 | 17 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ELOA ERCC5 HDAC6 BUD13 ZNF318 HDAC7 EEF2 INTS5 KANSL1 PDCD5 ZNF516 TRAPPC10 PLEC NOTCH2 ALPI | 2.73e-05 | 774 | 191 | 15 | 15302935 |
| Pubmed | 2.89e-05 | 107 | 191 | 6 | 11347906 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 28765216 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 17332894 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 12798794 | ||
| Pubmed | p100/IκBδ sequesters and inhibits NF-κB through kappaBsome formation. | 3.00e-05 | 2 | 191 | 2 | 25349408 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 17442975 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 12919939 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 17548480 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 39358382 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 22470186 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 22470185 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 7867067 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23927892 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23447685 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 26892079 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 21098741 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 16525990 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 32400230 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 20810988 | ||
| Pubmed | Silica suppresses Toll-like receptor ligand-induced dendritic cell activation. | 3.00e-05 | 2 | 191 | 2 | 18180331 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 16339556 | ||
| Pubmed | Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. | 3.00e-05 | 2 | 191 | 2 | 16882874 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 24813994 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 12496659 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 29769337 | ||
| Pubmed | FLG SAMD1 XIRP1 HDAC6 MTMR1 ZNF318 KLF4 RIOX2 STIM1 NHSL1 TRMT6 ZNF516 FGD5 FGD6 | 3.05e-05 | 689 | 191 | 14 | 36543142 | |
| Pubmed | SMG1 UBAP2 SASH1 ZNF212 MARCHF6 ANKRD50 STOX2 INTS5 TRMT6 HECW2 ZNF516 EHMT1 | 4.01e-05 | 529 | 191 | 12 | 14621295 | |
| Pubmed | 7.07e-05 | 15 | 191 | 3 | 17194759 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SAMD1 ZNF536 SLC4A7 HDAC6 HK3 MYO9B PATZ1 MTMR1 WWTR1 ADAR KANSL1 DMKN NFKB2 BANP NOTCH2 | 8.58e-05 | 857 | 191 | 15 | 25609649 |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 28258168 | ||
| Pubmed | Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity. | 8.97e-05 | 3 | 191 | 2 | 17827213 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 21478494 | ||
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 38952869 | ||
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 23698468 | ||
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 8.97e-05 | 3 | 191 | 2 | 28928464 | |
| Pubmed | Protein tyrosine phosphatase zeta/RPTPbeta interacts with PSD-95/SAP90 family. | 8.97e-05 | 3 | 191 | 2 | 10521598 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 32437351 | ||
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 23419067 | ||
| Pubmed | MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. | 8.97e-05 | 3 | 191 | 2 | 16984918 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 28572448 | ||
| Pubmed | Genome-Wide Association Study to Identify Genes Related to Renal Mercury Concentrations in Mice. | 8.97e-05 | 3 | 191 | 2 | 26942574 | |
| Pubmed | Notch signaling drives multiple myeloma induced osteoclastogenesis. | 8.97e-05 | 3 | 191 | 2 | 25257302 | |
| Pubmed | Genetic variations in scavenger and β₂-adrenergic receptors and risk of pulmonary disease. | 8.97e-05 | 3 | 191 | 2 | 25186548 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 16510300 | ||
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 17602227 | ||
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 32193376 | ||
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 8.97e-05 | 3 | 191 | 2 | 18458347 | |
| Pubmed | ANKS4B Is Essential for Intermicrovillar Adhesion Complex Formation. | 8.97e-05 | 3 | 191 | 2 | 26812018 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 22549787 | ||
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 8.97e-05 | 3 | 191 | 2 | 23403047 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 23043102 | ||
| Pubmed | PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia. | 8.97e-05 | 3 | 191 | 2 | 27299860 | |
| Pubmed | Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. | 8.97e-05 | 3 | 191 | 2 | 16339540 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 31001581 | ||
| Pubmed | Silica-directed mast cell activation is enhanced by scavenger receptors. | 8.97e-05 | 3 | 191 | 2 | 16902192 | |
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 8.97e-05 | 3 | 191 | 2 | 37330998 | |
| Pubmed | ZNF536 PPRC1 ZNF423 URB2 TENM4 KANSL1 DOCK7 COBL ASB1 BOD1L1 | 9.26e-05 | 407 | 191 | 10 | 12693553 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG NOL4 ELOA HDAC6 ZNF423 MTMR1 BUD13 FLG2 ADAR DDB1 EEF2 INTS5 MOGS DOCK7 EHMT1 PLEC HNRNPLL | 1.08e-04 | 1082 | 191 | 17 | 38697112 |
| Pubmed | SLC4A7 ERCC5 HDAC6 HK3 PPRC1 ZNF212 ZNF318 ANKRD50 KLF4 SDR39U1 BMP8B EML5 TRAPPC10 BOD1L1 PLEC IL17RD SLX4 | 1.10e-04 | 1084 | 191 | 17 | 11544199 | |
| Pubmed | 1.10e-04 | 45 | 191 | 4 | 22114352 | ||
| Pubmed | 1.25e-04 | 18 | 191 | 3 | 18093989 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ELOA SCO2 SLC4A7 UBAP2 MAN2A2 HDAC6 SEMA7A MCCC1 ADAR DDB1 STIM1 EEF2 LMF2 MOGS GOLIM4 NID1 LSS PLEC ADAMTS14 NOTCH2 | 1.55e-04 | 1451 | 191 | 20 | 30550785 |
| Pubmed | ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion. | 1.79e-04 | 4 | 191 | 2 | 30538141 | |
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 28394332 | ||
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 20133774 | ||
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 24398584 | ||
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 37741944 | ||
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 28338748 | ||
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 17893199 | ||
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 26080397 | ||
| Pubmed | A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses. | 1.79e-04 | 4 | 191 | 2 | 20162551 | |
| Pubmed | Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A. | 1.79e-04 | 4 | 191 | 2 | 22753077 | |
| Pubmed | The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74. | 1.79e-04 | 4 | 191 | 2 | 22140262 | |
| Pubmed | 1.79e-04 | 4 | 191 | 2 | 12711551 | ||
| Pubmed | SMG1 ZNF536 ZNF142 ZNFX1 URB2 CCDC85A ADAMTS6 ZNF516 EHMT1 FGD5 IL17RD AHNAK2 | 2.31e-04 | 638 | 191 | 12 | 31182584 | |
| Pubmed | 2.42e-04 | 55 | 191 | 4 | 36758106 | ||
| Pubmed | 2.66e-04 | 23 | 191 | 3 | 14701881 | ||
| Pubmed | Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. | 2.66e-04 | 23 | 191 | 3 | 23386589 | |
| Pubmed | Crbn modulates calcium influx by regulating Orai1 during efferocytosis. | 2.97e-04 | 5 | 191 | 2 | 33127885 | |
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 25855559 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 16672719 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 16899352 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 2169617 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 19880493 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 38918046 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.97e-04 | 5 | 191 | 2 | 15064243 | |
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 35922041 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 24563502 | ||
| Pubmed | 2.97e-04 | 5 | 191 | 2 | 19521507 | ||
| Pubmed | AP-2α and AP-2β regulate dorsal interneuron specification in the spinal cord. | 2.97e-04 | 5 | 191 | 2 | 27984181 | |
| Interaction | TOP3B interactions | EPHB4 SCO2 UBAP2 MAN2A2 SEMA7A MYO9B PPRC1 PAPLN KLF4 HDAC7 ZFP36 JAG2 NHSL1 BMP8B RADIL INTS5 KANSL1 MOGS NAPRT NFKB2 ZNF516 BANP EHMT1 COBL PLA2G6 PLEC HERC2 IL17RD FEM1A MYRF ADAT1 NOTCH2 AHNAK2 | 1.86e-06 | 1470 | 187 | 33 | int:TOP3B |
| GeneFamily | Ankyrin repeat domain containing | ANKUB1 NFKBID ANKRD50 ANKS4B NFKB2 EHMT1 PLA2G6 ASB1 TNKS FEM1A NOTCH2 | 4.50e-07 | 242 | 116 | 11 | 403 |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 8.84e-06 | 7 | 116 | 3 | 1350 | |
| GeneFamily | Sterile alpha motif domain containing | 2.16e-05 | 88 | 116 | 6 | 760 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF449 ZNF536 ZNF142 PATZ1 ZNF423 ZNF212 ZNF233 ZKSCAN2 ZNF318 ZNF275 KLF4 ZIC4 ZNF516 ZSCAN2 ZNF443 | 5.52e-05 | 718 | 116 | 15 | 28 |
| GeneFamily | Adenosine deaminases acting on RNA | 1.11e-03 | 8 | 116 | 2 | 1303 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | CACNA1D TRIM15 TMED6 MYO7B ACY3 ANKS4B LINC00336 CREB3L1 RNASE4 CALML4 CAPN5 MYRF | 4.70e-12 | 159 | 190 | 12 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | SASH1 ZNF423 WWTR1 TGFBR3 STOX2 ADAMTS6 RAPGEF3 HECW2 FGD5 NOS1 | 8.85e-09 | 188 | 190 | 10 | d582b76fc2faac526c9bf97503041129e1a6a211 |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-08 | 168 | 190 | 9 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 200 | 190 | 9 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.13e-07 | 170 | 190 | 8 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.45e-07 | 171 | 190 | 8 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 180 | 190 | 8 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 190 | 190 | 8 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 190 | 190 | 8 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 194 | 190 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.15e-06 | 197 | 190 | 8 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 2.15e-06 | 197 | 190 | 8 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-06 | 198 | 190 | 8 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-06 | 198 | 190 | 8 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-06 | 198 | 190 | 8 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 200 | 190 | 8 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.41e-06 | 200 | 190 | 8 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 2.41e-06 | 200 | 190 | 8 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.82e-06 | 164 | 190 | 7 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.67e-06 | 173 | 190 | 7 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.67e-06 | 173 | 190 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 1.00e-05 | 174 | 190 | 7 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 175 | 190 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.16e-05 | 178 | 190 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.30e-05 | 181 | 190 | 7 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 182 | 190 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 182 | 190 | 7 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 183 | 190 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 183 | 190 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.39e-05 | 183 | 190 | 7 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.44e-05 | 184 | 190 | 7 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 184 | 190 | 7 | 16ed515fb673a9d6973133afcda0a3fba4a8d9dc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 185 | 190 | 7 | 3189e91fe26df59bd605d2b6223ceb1779daf0b8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 186 | 190 | 7 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-05 | 186 | 190 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 186 | 190 | 7 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-05 | 186 | 190 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.60e-05 | 187 | 190 | 7 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 187 | 190 | 7 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.66e-05 | 188 | 190 | 7 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 188 | 190 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 1.66e-05 | 188 | 190 | 7 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-05 | 189 | 190 | 7 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 189 | 190 | 7 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 189 | 190 | 7 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 189 | 190 | 7 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 190 | 190 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 190 | 190 | 7 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-05 | 192 | 190 | 7 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 193 | 190 | 7 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 193 | 190 | 7 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 193 | 190 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 193 | 190 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 193 | 190 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 193 | 190 | 7 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 193 | 190 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 194 | 190 | 7 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 194 | 190 | 7 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 194 | 190 | 7 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-05 | 194 | 190 | 7 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 194 | 190 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 194 | 190 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-05 | 194 | 190 | 7 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 194 | 190 | 7 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.10e-05 | 195 | 190 | 7 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-05 | 195 | 190 | 7 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 196 | 190 | 7 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-05 | 196 | 190 | 7 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 196 | 190 | 7 | c5adc95df9e1d1884a7988336e459a98c5a6769b | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 196 | 190 | 7 | 81d1fd63397b2cf893607d828b61a926fa65185f | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 197 | 190 | 7 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-05 | 197 | 190 | 7 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.24e-05 | 197 | 190 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | ILEUM-inflamed-(7)_CD36+_endothelial_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.31e-05 | 198 | 190 | 7 | 05d6558c7990ad2277db999025a073d29b273dfc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 198 | 190 | 7 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.31e-05 | 198 | 190 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-05 | 198 | 190 | 7 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 198 | 190 | 7 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.31e-05 | 198 | 190 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 198 | 190 | 7 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 199 | 190 | 7 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 199 | 190 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 199 | 190 | 7 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.39e-05 | 199 | 190 | 7 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 190 | 7 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.47e-05 | 200 | 190 | 7 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 2.47e-05 | 200 | 190 | 7 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 190 | 7 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 190 | 7 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 200 | 190 | 7 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 190 | 7 | 85e1b598c9f3976215b20eeda077d8aab621cce6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT-L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 190 | 7 | 2f2c5331511a924fa0bb1689f4c81641d754c9b9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 190 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 190 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial-Proteoglycan-expressing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 190 | 7 | 94ef227b2162ba77af33b8cc8aaa4a7e3bdf79a7 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 2.47e-05 | 200 | 190 | 7 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-05 | 200 | 190 | 7 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.47e-05 | 200 | 190 | 7 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| Disease | 2-stearoylglycerophosphocholine measurement | 3.83e-05 | 2 | 183 | 2 | EFO_0021098 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 6.41e-05 | 13 | 183 | 3 | OBA_2045159 | |
| Disease | Dandy-Walker syndrome (implicated_via_orthology) | 1.14e-04 | 3 | 183 | 2 | DOID:2785 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | EPHB4 XIRP1 TFAP2D HK3 ZNF318 ADAR HDAC7 JAG2 EEF2 LMF2 EHMT1 GOLIM4 CD74 BOD1L1 FGD5 PLD2 HERC2 NOTCH2 | 1.34e-04 | 1074 | 183 | 18 | C0006142 |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 1.79e-04 | 18 | 183 | 3 | OBA_2045155 | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 3.78e-04 | 5 | 183 | 2 | DOID:11723 (is_marker_for) | |
| Disease | sleep duration, triglyceride measurement | 4.86e-04 | 104 | 183 | 5 | EFO_0004530, EFO_0005271 | |
| Disease | nevus | 5.65e-04 | 6 | 183 | 2 | EFO_0000625 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 6.86e-04 | 28 | 183 | 3 | EFO_0600005 | |
| Disease | hypertension | 6.96e-04 | 307 | 183 | 8 | EFO_0000537 | |
| Disease | obsolete_red blood cell distribution width | PMS2P1 UNC119B SCO2 TRIM15 MYO9B PATZ1 SCG5 MFSD2B BUD13 PAPLN KANSL1 HECW2 PDCD5 ZNF516 BANP YDJC PLA2G6 ALDH6A1 ZNF443 | 7.45e-04 | 1347 | 183 | 19 | EFO_0005192 |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 7.61e-04 | 29 | 183 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | response to angiotensin receptor blocker | 8.42e-04 | 30 | 183 | 3 | EFO_0010735 | |
| Disease | schizophrenia (implicated_via_orthology) | 8.56e-04 | 68 | 183 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | XIRP1 TMED6 MAN2A2 SEMA7A BUD13 CRTAC1 ADAR CREB3L1 BANP DOCK7 YDJC PLA2G6 TRIM40 MYRF | 8.74e-04 | 848 | 183 | 14 | EFO_0004614 |
| Disease | mean arterial pressure | CACNA1D SLC4A7 TFAP2D MYO9B ZNF423 EML6 ZNF318 HDAC7 CREB3L1 FGD5 | 1.17e-03 | 499 | 183 | 10 | EFO_0006340 |
| Disease | right ventricular systolic volume measurement | 1.33e-03 | 35 | 183 | 3 | EFO_0021815 | |
| Disease | pulmonary function measurement, forced expiratory volume | 1.56e-03 | 37 | 183 | 3 | EFO_0003892, EFO_0004314 | |
| Disease | overweight body mass index status | 2.03e-03 | 11 | 183 | 2 | EFO_0005935 | |
| Disease | sleep disorder (implicated_via_orthology) | 2.03e-03 | 11 | 183 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.15e-03 | 145 | 183 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | cholesteryl ester 20:4 measurement | 2.58e-03 | 44 | 183 | 3 | EFO_0010348 | |
| Disease | hippocampal volume | 2.63e-03 | 297 | 183 | 7 | EFO_0005035 | |
| Disease | pulse pressure measurement | EPHB4 CACNA1D SLC4A7 ANKUB1 ZNF423 CRTAC1 ZNF318 SPTBN4 TGFBR3 MALRD1 TENM4 KANSL1 ZNF516 CDYL2 YDJC FGD5 FGD6 FILIP1L | 2.66e-03 | 1392 | 183 | 18 | EFO_0005763 |
| Disease | platelet component distribution width | EPHB4 SLC4A7 MYO9B CRTAC1 RDH13 HDAC7 STIM1 RAPGEF3 DOCK7 PLA2G6 PLEC FGD6 | 2.77e-03 | 755 | 183 | 12 | EFO_0007984 |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.85e-03 | 13 | 183 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.85e-03 | 13 | 183 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.85e-03 | 13 | 183 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 2.85e-03 | 13 | 183 | 2 | C4551952 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 2.85e-03 | 13 | 183 | 2 | EFO_0800413 | |
| Disease | apolipoprotein E measurement | 2.85e-03 | 13 | 183 | 2 | EFO_0008029 | |
| Disease | Congenital Structural Myopathy | 2.85e-03 | 13 | 183 | 2 | C0752282 | |
| Disease | smoking status measurement, systolic blood pressure | 2.95e-03 | 156 | 183 | 5 | EFO_0006335, EFO_0006527 | |
| Disease | sunburn | 3.05e-03 | 96 | 183 | 4 | EFO_0003958 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.31e-03 | 14 | 183 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 3.31e-03 | 14 | 183 | 2 | C0410207 | |
| Disease | platelet measurement | 3.64e-03 | 315 | 183 | 7 | EFO_0005036 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 3.71e-03 | 50 | 183 | 3 | EFO_0010732 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.81e-03 | 15 | 183 | 2 | C3645536 | |
| Disease | epithelial cell adhesion molecule measurement | 3.93e-03 | 51 | 183 | 3 | EFO_0010574 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 4.34e-03 | 16 | 183 | 2 | EFO_0800184 | |
| Disease | diacylglycerol 36:2 measurement | 4.34e-03 | 16 | 183 | 2 | EFO_0010355 | |
| Disease | Dermatitis | 4.34e-03 | 16 | 183 | 2 | C0011603 | |
| Disease | mean reticulocyte volume | UNC119B SCO2 MYO9B PPRC1 ZNF318 URB2 HDAC7 STIM1 KANSL1 PDCD5 DBR1 TMUB2 | 4.34e-03 | 799 | 183 | 12 | EFO_0010701 |
| Disease | Muscle hypotonia | 4.89e-03 | 17 | 183 | 2 | C0026827 | |
| Disease | esophageal carcinoma, gastric carcinoma | 4.89e-03 | 17 | 183 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | Congenital Fiber Type Disproportion | 5.48e-03 | 18 | 183 | 2 | C0546264 | |
| Disease | diacylglycerol 36:3 measurement | 5.48e-03 | 18 | 183 | 2 | EFO_0020062 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 5.48e-03 | 18 | 183 | 2 | OBA_2045065 | |
| Disease | erythrocyte measurement | 5.50e-03 | 257 | 183 | 6 | EFO_0005047 | |
| Disease | smoking status measurement | CACNA1D NOL4 TFAP2D ANKUB1 ZNF423 GATB ADAR SPTBN4 ZIC4 TENM4 KANSL1 PTPRG ELFN1 HECW2 ADAT1 | 5.96e-03 | 1160 | 183 | 15 | EFO_0006527 |
| Disease | hippocampal tail volume | 6.10e-03 | 19 | 183 | 2 | EFO_0009398 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 6.10e-03 | 19 | 183 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | Alopecia | 6.10e-03 | 19 | 183 | 2 | C0002170 | |
| Disease | retinal layer thickness measurement | 6.20e-03 | 60 | 183 | 3 | EFO_0600002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NRTAEGGHQTIPGHE | 631 | P23470 | |
| RQGEEAIGNPHHVSL | 1331 | Q14146 | |
| DSEGNLQIHHVGQDG | 411 | Q8N9N5 | |
| NRGHSVLVDEGHSSP | 131 | Q5RHP9 | |
| NSRSHGLETVPGHQR | 11 | Q8TF63 | |
| LGGHNEDLPSNRHFR | 106 | Q9BRD0 | |
| HRGDKGNEENPHRFD | 291 | O60512 | |
| GGPAEQRPRDHLQHD | 456 | Q96BA8 | |
| GHSLQRHHSVEAAGP | 621 | P0C7U0 | |
| AGHLAGTVHPQLQDR | 236 | Q96HD9 | |
| RQSQEGAGLPSHHGR | 106 | Q92754 | |
| EVQRHLQTHGIDGNG | 91 | Q96GE6 | |
| AERGGQHSSSQQLPH | 91 | P0DPF5 | |
| LEAGADPNGSRHHRS | 131 | Q9Y576 | |
| PAHDAPGASVLQNEH | 236 | Q86SQ6 | |
| DAAHRVHPLAGQGVN | 366 | Q9Y2Z9 | |
| GTESELQNHRPTGHL | 4171 | Q86UQ4 | |
| GQLRVDANISVHHPG | 256 | O75879 | |
| PQSIEGGAHEGLQHL | 71 | P05408 | |
| EHGADPNHADQFGRT | 1066 | Q9ULJ7 | |
| HEDPRQNRGGGCINH | 366 | O15484 | |
| HSASQEGQDTIRGHP | 506 | P20930 | |
| HGSAQEQSRDGSRHP | 646 | P20930 | |
| GPSTGVRQGSHHEQA | 811 | P20930 | |
| HSASQDGQDTIRGHP | 831 | P20930 | |
| QSRDGSRHPGFHQED | 1301 | P20930 | |
| AGPHQQSHKESARGQ | 1416 | P20930 | |
| SPGERHGSRHQQSAD | 1676 | P20930 | |
| HSASQDGQDTIRGHP | 2776 | P20930 | |
| HGSAQEQLRDGSRHP | 2916 | P20930 | |
| EDHQHGRATQLPGAL | 1141 | Q8WXS8 | |
| QSDGNTIPENGIAHH | 336 | Q9UKP5 | |
| PGTAAREVTNGAAHH | 201 | Q9BUB4 | |
| PGLVHDAEIRHDGSN | 6 | Q7Z6R9 | |
| GLPHFGEHSSRVVQE | 201 | Q9NP87 | |
| GHGNDNHADADRSPI | 486 | Q13613 | |
| PRTSEQHRQGSDGNH | 96 | Q6PCD5 | |
| QHRQGSDGNHTIPAS | 101 | Q6PCD5 | |
| QAILGEHPSSFRHDG | 276 | Q8WVV9 | |
| PGAHISVNFSEVGHR | 321 | Q96JH8 | |
| DAIEHNGHSRPGTAT | 421 | Q9P2P5 | |
| PDGTLNIIHGQHEAV | 231 | Q02252 | |
| NAAERTPSHSGHLQG | 2396 | Q04721 | |
| QLQAHDPDAGANGHV | 1876 | Q96JQ0 | |
| QLQLLAHDGPHEGRA | 2346 | Q96JQ0 | |
| AHDGPHEGRANLTVL | 2351 | Q96JQ0 | |
| EVHSGGSHRPQSQEQ | 1431 | Q5D862 | |
| EFLHRQHTEEGGGPL | 201 | Q9H3H1 | |
| NGHRPAAHDFPLGRQ | 296 | O43474 | |
| EDEHVRAPTGHHQAG | 51 | P13349 | |
| HGVVLRPPENHNAGE | 251 | Q9HBL6 | |
| HGLQEPGQHTRQGSR | 516 | Q8NFM7 | |
| GPFGQEHHSQTQLDE | 516 | P54760 | |
| GSPQHQDLAGQLVVH | 166 | Q9BRQ3 | |
| VRPEGAGKVQSHHNE | 581 | Q6ZRS4 | |
| HNTRHTFGRINEPGQ | 2741 | O95714 | |
| PNAADHQGRSVLHVA | 111 | Q8NI38 | |
| RGDAHHISPDGVLLQ | 2496 | Q8NDA2 | |
| HNPAGEDARLHTVNV | 3301 | Q8NDA2 | |
| HFNRDHVPQGTTVGA | 976 | Q9Y219 | |
| EHRQNPVRGAHSQGE | 516 | Q4FZB7 | |
| HSAAGHDGAQPLRVL | 381 | A8MWA6 | |
| QRGHPQADENLGHLG | 361 | Q5SYE7 | |
| HGDPGDAAQQEAKHR | 21 | O14737 | |
| GSHRQTPDFGEHLAL | 296 | Q9H1Q7 | |
| HEREHILGAAGATDP | 851 | P14543 | |
| HIEHSVRGQGDLLQP | 1096 | Q6ZNL6 | |
| FAIQALLEAGGHHRP | 391 | P48449 | |
| SQPLENHGARIIGHI | 516 | Q7Z3B3 | |
| AIPVVGEGLHAAHQA | 596 | O60337 | |
| VVDDFQLQHRHGPGL | 396 | A6NFX1 | |
| SHPENRNGADHLLAD | 36 | Q6X4W1 | |
| LQVLDQHPVGTGDHR | 346 | Q29980 | |
| QHPVGTGDHRDAAQL | 351 | Q29980 | |
| GGAPVEELRHLAHAN | 516 | Q96KJ4 | |
| EHGRTAVRHQPGQAG | 171 | Q96N21 | |
| EDGSVHHESILNRPG | 256 | Q8N8V4 | |
| GGHRPENFLHQVLTE | 6 | A4D2B8 | |
| RLGADPAHQDRHGDT | 86 | Q9UBC1 | |
| RHGDTALHAAARQGP | 96 | Q9UBC1 | |
| AGQGAPLSETRFHHV | 106 | Q6ZUF6 | |
| NGHVAITAVSPHRDG | 1371 | P23471 | |
| HRVGALDERGHPNPQ | 96 | Q9Y6Z4 | |
| DHTLDHESLNPGAQR | 291 | P52790 | |
| PAHQHEAALRGLAGA | 86 | O95402 | |
| NALHPGVARTELGRH | 226 | Q8NBN7 | |
| HDGLSFGRQHIQDGA | 151 | Q13724 | |
| SGPHEGRVEILHSGQ | 356 | P21757 | |
| DHLGVFPGNHEDLVN | 1036 | P29475 | |
| QHQDEAEGDPGNRHE | 511 | O00461 | |
| RGPQAHLVHGVQEQS | 461 | P09923 | |
| GFSRPDHLNGHIKQV | 421 | Q9HBE1 | |
| SRHQEPILNGGAAFH | 526 | Q9HBE1 | |
| NGISIHHGEENHRPS | 1121 | Q5VYJ5 | |
| APRAASHGVGRHQEL | 26 | Q9H094 | |
| GTHSRNNPLHVGAEA | 1566 | Q8NFC6 | |
| TVGHQAHGREQSTLP | 416 | Q8IZD4 | |
| QHGQAAEKGPHRSRD | 61 | Q6UWH4 | |
| SAIAHRGGSHDAPEN | 66 | Q9NZC3 | |
| GALDVSPHATGHQQE | 221 | P0C671 | |
| PFTLDGRAHGELHEQ | 1946 | Q96N67 | |
| QHSGVVRPDGHSQGA | 206 | P55265 | |
| EAAHALGNTGHEIGR | 101 | Q6E0U4 | |
| DRLGASQERHLGEPH | 246 | Q14241 | |
| HQFGNHIEGSPERDP | 191 | A8K855 | |
| PHSGNGHQAEDLSRD | 56 | Q4L180 | |
| AHHEGRNPLGEGRNQ | 821 | O75128 | |
| VGEHQADLEVANRHG | 136 | Q9BSK4 | |
| FGDLSHQLDQPGHSD | 216 | Q9NQY0 | |
| LVTDFSHREDQHGGP | 341 | A2IDD5 | |
| GTLRRQAQEDGSPHH | 391 | Q96PX6 | |
| LLQSAHPGEHLAQGA | 96 | Q9UEW3 | |
| HPGEHLAQGASRLQV | 101 | Q9UEW3 | |
| LNLSGHPEFEAGNVH | 471 | Q96RQ3 | |
| LDRVQHDPTRHQNGG | 26 | P49641 | |
| IGGNHEASNHLQELP | 81 | Q9UK59 | |
| AVRSHHHEPAGETGN | 76 | Q6UW01 | |
| DDPHQHGRGVALADF | 286 | Q9NQ79 | |
| DVTLHADAIHRGGGQ | 706 | P13639 | |
| EDNPSIRAISLGHGH | 956 | Q05BV3 | |
| EDNPSIRAITLGHGH | 956 | Q6ZMW3 | |
| SHHLPNRVGSGAYEQ | 341 | Q5T8I3 | |
| NGTEVPNTRSRGHHN | 256 | P04233 | |
| LEANHVHGVLNGVAP | 206 | Q9NRG7 | |
| GAAVVRPPGHHAEQD | 601 | Q9UBN7 | |
| GDNSRHPEHAGRIQS | 536 | Q8WUI4 | |
| PGIFDDVHGSHGRQV | 286 | P34820 | |
| PESDRPAGAQHHQLN | 351 | Q6SPF0 | |
| HHQLNGERGPQSAKE | 361 | Q6SPF0 | |
| LGEQGLPHQSHRQRS | 646 | P51172 | |
| QAAVGQGDFHLLDHR | 96 | O43819 | |
| NIHGDSPLHIAAREN | 936 | Q9H9B1 | |
| AKHPAAVRLQEGVHG | 1271 | Q5VV67 | |
| AAHGKRPSIGNLEHV | 1766 | Q01668 | |
| RPSIGNLEHVSENGH | 1771 | Q01668 | |
| RNGIGIHEHASIDLP | 391 | Q16531 | |
| HSAAGHDGAQPLRVL | 381 | P0C7X0 | |
| GHEPRQTTSNLGHLN | 171 | O00487 | |
| HAQAGELLSPGHARS | 16 | O60422 | |
| DHGNHRLEAGPESQH | 151 | Q6P9F5 | |
| NSLAAVRSPREGHGH | 206 | Q6ZMC9 | |
| HSDPHLLERNGEGLS | 241 | Q9Y6M7 | |
| EAAHHAGPELQRTGR | 566 | Q9Y6M7 | |
| LDDQHLAAEPGHGSR | 286 | Q9BU23 | |
| GAEGVDHPSHTLQHR | 2521 | Q96Q15 | |
| GVRDRHGNSIENPHL | 41 | P28715 | |
| ANADARGEHGNTPLH | 341 | O60733 | |
| GHRAGAAVDLGHEQV | 26 | Q86UD7 | |
| GVDPILGHQLSAREH | 41 | Q6P9B9 | |
| GQHQRVPHATGALNE | 161 | Q6P9B9 | |
| PQHGLGSQRDLTHSD | 506 | Q13586 | |
| HVETGPNGEQIRKHA | 116 | O94818 | |
| VHAQQEATTGPGAHR | 1641 | Q8IY92 | |
| GQPENDIDRILHSHG | 141 | Q8N0Z2 | |
| VVHEGDLHDPSRDGN | 4671 | Q8IVF2 | |
| ALKQGARPHEAVGVH | 211 | A6NFN9 | |
| DERHFGNGSHQPGLD | 166 | Q8N8U2 | |
| AAGLPVEHHTFRLQG | 16 | Q8N6V4 | |
| FLRQHVHPEETGGSD | 36 | P34096 | |
| HFHVEPAGGSEQERS | 441 | O95398 | |
| LSHIERDHITAQGPG | 216 | Q92618 | |
| HHLPQDAQSGSGQRS | 1081 | Q5T6F2 | |
| SHGVLQHTQGLPADR | 71 | Q15654 | |
| RLQGHSPGEDHGEVV | 186 | Q7Z7L9 | |
| LVRDSSHPNKAGQGH | 316 | Q9ULX5 | |
| SRNGLPVQADGHRVH | 1166 | O95428 | |
| PVQADGHRVHQSPDG | 1171 | O95428 | |
| GLEVDHTPAGQAIHS | 346 | A6NFA1 | |
| ANGRLVQHHGAEPSS | 676 | Q9P2F5 | |
| NVHARDDGGLIPLHN | 241 | O95271 | |
| REGPTHQAHTVGFLD | 106 | Q9C019 | |
| DGQLQLGPRHQHSSS | 801 | Q6ZV73 | |
| SLNGHHEIVQPGRVF | 1076 | Q6ZV73 | |
| RDLPEFGTQGGVHVH | 41 | O75191 | |
| FAHGLGELRQANRHP | 126 | P26651 | |
| RRQAPHHAADDGVGA | 41 | A6NIH7 | |
| QRQGEDLAHVQHPTG | 91 | Q9NW97 | |
| DRHVAATAHNPQGFL | 81 | Q8WW62 | |
| HDTSPLLLGRGQDAH | 31 | Q6ZNK6 | |
| VIQGHQPRDNHTDHG | 271 | Q9Y385 | |
| QPRDNHTDHGGSAVL | 276 | Q9Y385 | |
| RELLGRAPTHADGHQ | 121 | A8MPS7 | |
| NTETDHPGGLQNHAR | 161 | Q6N022 | |
| HHPLGTKEGVDAEQR | 961 | O94885 | |
| HVGQDRVDFGQTEPH | 61 | O75326 | |
| NHTVQELVEGGHPSS | 941 | Q9H254 | |
| LGGQHRVPQAAQLHS | 726 | Q4G0T1 | |
| LGHVDHLVAGQGNPE | 81 | Q71RG4 | |
| EQVCAHLGLGVQEPH | 251 | Q6XQN6 | |
| PSVEAQLGSHRGLHQ | 686 | Q15149 | |
| RGTIHQADTPAGLAH | 236 | Q8IUF8 | |
| NPHQGRRNQEGHASD | 76 | Q9P2E3 | |
| QPQHPGDHRIRDGDF | 11 | Q9UJA5 | |
| HHRERQNGAGPLSGQ | 801 | O15090 | |
| THVTVEHVGGPEQAN | 156 | Q8N9L1 | |
| RFLQGHEKTHTGENP | 601 | Q9Y2A4 | |
| EGFSQGSHLQPHQRV | 321 | A6NK53 | |
| GSHLQPHQRVSTGEN | 326 | A6NK53 | |
| HLQEGPSAGQHVQER | 391 | Q9UDV6 | |
| AVSREEPGSLHSGHQ | 166 | Q63HK3 | |
| EPGSLHSGHQEQLNR | 171 | Q63HK3 | |
| GHRAGAAVDLGHEQV | 26 | Q2M2D7 | |
| SENGLREHLQTHRGP | 941 | Q2M1K9 | |
| RRHHPDQADPNQGVG | 1641 | P52746 | |
| LHFDPSNAVVHVGGV | 591 | P48553 | |
| QPERQDGDSHHGQPE | 136 | Q6XPR3 | |
| DGDSHHGQPERQDRD | 141 | Q6XPR3 | |
| HGQPERQDRDSHHGQ | 146 | Q6XPR3 | |
| GVNGLAEHQRIHSGA | 276 | Q9NSD4 | |
| QGPGRDFLQLHRHDS | 311 | O14939 | |
| HLQRVDPQDGEGHLS | 401 | Q702N8 | |
| IGPHSIDDSNLNHGN | 1801 | Q5VUA4 | |
| SQLTGHQRIHSGEEP | 336 | Q6P9G9 | |
| AETEERNFPHGNEHL | 146 | Q03167 | |
| GAAGSPAQQHAHLRQ | 101 | Q9GZV5 | |
| LRGAATEQGAPHFLH | 651 | A6NNM8 | |
| VHESPQLHQNEGLAG | 1016 | O94898 | |
| DTLGREHGAQVPQHS | 1046 | Q6PIF6 | |
| LEAPSGQQHRHAAGE | 1456 | Q13459 | |
| PDTVFHHGRVGINTD | 551 | Q9Y2G1 | |
| HHGRVGINTDRPDEA | 556 | Q9Y2G1 | |
| ENGDTPLHLAIIHGQ | 486 | Q00653 |